The AP-HP, the Federation of Diabetological Hospital Services (Bichat Hospital, Professor Roussel, Cochin Hospital, Prof. Larger, Lariboisière Hospital, Professor Gautier) and the AP-HP Connected Health Responsibility Centre (Dr Boris Hansel Pr Patrick Nataf) offer this week to diabetic patients confined at home during this period of Covid-19 outbreak a national programme of information, prevention and support for their health.
“Diabetes is one of the situations at risk of severe COVID-19 infection,” recalls Professor Ronan Roussel, diabetologist at the Bichat Hospital. “According to preliminary Chinese studies, it multiplies by 2 to 4 the risk of death due to this infection and patients with diabetes are likely to question their personal risk.” To meet this expectation, the Federation of diabetology proposes, at national level, concrete assistance based on e-health.
A collaborative initiative of teams of the AP-HP, Inserm and University of Paris.
The application is based on the IRIADE platform. Diabetic patients can register themselves or through a doctor on the website www.covidiab.fr
Therefore, the diabetic patient accesses a media library updated daily. Notifications are sent every time an information useful for diabetic patients is published. In addition, through questionnaires, personalized advice are provided. Finally, questions on health status are regularly asked to refer the patient to specific treatments according to updated recommendations (GP, EMS, ER) if necessary by promoting teleconsultation. The system provides for physicians who wish it the supervision of individual alerts allowing them to work directly with their patients.
LIVE video sessions are offered to Covidiab registrants with diabetologists, hygienists and infectiologists.
The application is intended for all diabetic patients residing in France (mainland and overseas).
“The project involves teams INSERM U1148 (LVTS connected health director Didier Letourneur) and U1138 (IMMEDIAB, Director: Nicolas Venteclef) , AP-HP Research Foundation and University of Paris.
This project has also received the support of the Youtube channel PuMS: https://www.youtube.com/pumsuniv
In response to the 2014-2016 Ebola epidemic, the clinical development of a two-dose regimen of vaccines Ad26.ZEBOV and MVA-BN-Filo was accelerated. Approved in 2020 by the European Commission for use in epidemic emergencies, this regimen continues to demonstrate its relevance. An Inserm ...
Alcohol consumption is both directly and indirectly implicated in the onset of some 60 diseases, making it a major health risk factor. In France, around 43 million people consume alcohol. Faced with its inherent health, social and financial impacts, the country’s Health ...